295
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Seroprevalence of anti-Toxoplasma gondii and anti-Borrelia species antibodies in patients with schizophrenia: a case–control study from western Turkey

, , , , &
Pages 230-236 | Received 10 Jun 2014, Accepted 15 Jan 2015, Published online: 16 Mar 2015

References

  • Ahmad D, Mehdi S, Sayed HH, Sayed AK, Shirzad G. 2010. Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Trop Biomed 27:476–482.
  • Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, et al. 2011. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int 60:151–155.
  • Bär KJ, Jochum T, Häger F, Meissner W, Sauer H. 2005. Painful hallucinations and somatic delusions in a patient with the possible diagnosis of neuroborreliosis. Clin J Pain 21:362–363.
  • Barnett W, Sigmund D, Roelcke U, Mundt C. 1991. [Endogenous paranoid-hallucinatory syndrome caused by Borrelia encephalitis]. Der Nervenarzt 62:445–447. [Article in German]
  • Brown JS. 1994. Geographic correlation of schizophrenia to ticks and tick-borne encephalitis. Schizophr Bull 20:755–775.
  • Cetinkaya Z, Yazar S, Gecici O, Namli MN. 2007. Anti-Toxoplasma gondii antibodies in patients with schizophrenia – preliminary findings in a Turkish sample. Schizophr Bull 33:789–791.
  • Cotter DR, Pariante CM, Everall IP. 2001. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55:585–595.
  • Corapcioğlu A. 1999. SCID-I Klinik versiyon, Hekimler Yayın Birliği Matbaası Ankara.
  • Creuzet C, Robert F, Roisin MP, Van Tan H, Benes C, Dupouy-Camet J, et al. 1998. Neurons in primary culture are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res 84:25–30.
  • da Silva RC, Langoni H. 2009. Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res 105:893–898.
  • Dickerson F, Boronow J, Stallings C, Origoni A, Yolken R. 2007. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr Bull 33:737–740.
  • Fallon BA, Nields JA, Parsons B, Liebowitz MR, Klein DF. 1993. Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry 54:263–268.
  • Fekadu A, Shibre T, Cleare AJ. 2010. Toxoplasmosis as a cause for behaviour disorders – overview of evidence and mechanisms. Folia Parasitol (Praha) 57:105–113.
  • First MB, Spitzer RL, Gibbon M, Williams JBW. 1996. Structured Clinical Interview for DSM-IV. New York: Biometrics Research Department New York State Psychiatric Institute.
  • Fritzsche M. 2002a. Seasonal correlation of sporadic schizophrenia to Ixodes ticks and Lyme borreliosis. Int J Health Geogr 1:2.
  • Fritzsche M. 2002b. Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia. Int J Health Geogr 1:5.
  • Fritzsche M. 2005. Chronic Lyme borreliosis at the root of multiple sclerosis – is a cure with antibiotics attainable? Med Hypotheses 64:438–448.
  • Grzywa A, Karakuła H, Górecka J, Chuchra M. 2004. [Delusional disorders in the course of tick-born encephalitis and borreliosis in patients with hemophilia A and posttraumatic epilepsy – diagnostic and therapeutic difficulties]. Polski Merkuriusz Lekarski 16:60–63. [Article in Polish]
  • Halonen SK, Lyman WD, Chiu FC. 1996. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol 55:1150–1156.
  • Halonen SK, Weiss LM. 2013. Toxoplasmosis. Handb Clin Neurol 114:125–145.
  • Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. 2009. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16:122–133.
  • Horacek J, Flegr J, Tintera J, Verebova K, Spaniel F, Novak T, et al. 2012. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J Biol Psychiatry 13:501–509.
  • Krause DL, Müller N. 2012. The Relationship between Tourette's syndrome and ınfections. Open Neurol J 6:124–128.
  • Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, et al. 2004. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254:4–8.
  • Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. 2011. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 199:440–444.
  • Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, et al. 2011. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133:150–155.
  • Park MH, Kwon YJ, Jeong HY, Lee HY, Hwangbo Y, Yoon HJ, et al. 2012. Association between ıntracellular ınfectious agents and schizophrenia. Clin Psychopharmacol Neurosci 10:117–123.
  • Pedersen MG, Stevens H, Pedersen CB, Pedersen BN, Mortensen PB. 2011. Toxoplasma ınfection and later development of schizophrenia in mothers. Am J Psychiatry 168:814–821.
  • Roelcke U, Barnett W, Wilder-Smith E, Sigmund D, Hacke W. 1992. Untreated neuroborreliosis: Bannwarth's syndrome evolving into acute schizophrenia-like psychosis. A case report. J Neurol 239:129–131.
  • Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL. 2008. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res 106:268–274.
  • Sno HN. 2012. [Signs and significance of a tick-bite: psychiatric disorders associated with Lyme disease]. Tijdschr Psychiatrie 54:235–243. [Article in Dutch]
  • Tamer GS, Dundar D, Yalug I, Caliskan S, Yazar S, Aker A. 2008. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both? Adv Ther 25:703–709.
  • Torrey EF, Bartko JJ, Lun ZR, Yolken RH. 2007. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 33:729–736.
  • Torrey EF, Yolken RH. 2003. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 9:1375–1380.
  • Torrey EF, Yolken RH. 2007. Editors’ Introduction: schizophrenia and toxoplasmosis. Schizophr Bull 33:727–728.
  • van den Bergen HA, Smith JP, van der Zwan A. 1993. [Lyme psychosis]. Ned Tijdschr Geneeskunde 137:2098–2100. [Article in Dutch].
  • Wang H, Yolken RH, Hoekstra PJ, Burger H, Klein HC. 2011. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study. Schizophr Res 129:47–51.
  • Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, et al. 2001. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 32:842–844.
  • Yolken RH, Dickerson FB, Fuller Torrey E. 2009. Toxoplasma and schizophrenia. Parasite Immunol 31:706–715.
  • Yolken RH, Torrey EF, Lieberman JA, Yang S, Dickerson FB. 2011. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 128:61–65.
  • Yuksel P, Alpay N, Babur C, Bayar R, Saribas S, Karakose AR, et al. 2010. The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia – the risk factor or an indication of a contact with cat? Folia Parasitol (Praha) 57:121–128.
  • Zhu S. 2009. Psychosis may be associated with toxoplasmosis. Med Hypotheses 73:799–801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.